Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Chief Technology Officer | September 01, 2020 | September 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date September 01, 2020 · Filed September 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 164,484 |
Ending reported balance
After 2020-09-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-09-01 · Exercise / conversion · Acquired 27,500 · Balance 191,984 Row 2 · 2020-09-01 · Sale · Disposed 14,090 · Balance 177,894 F1: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.86 to $31.85, inclusive. Row 3 · 2020-09-01 · Sale · Disposed 13,410 · Balance 164,484 F1: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.89 to $32.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.80 · Expires 2028-09-27 | Direct | 443,389 |
Reported balance
After 2020-09-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-09-01 · Exercise / conversion · Disposed 27,500 · Balance 443,389 F4: 25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1.
F2: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.86 to $31.85, inclusive.
F3: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.89 to $32.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
F4: 25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2020 Filed Sep 3, 2020 19:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-005870 · primarydocument.xml · derivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,389 Underlying: Common Stock · 27,500 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 19:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 13,410 | $32.06 | $429,924.60 |
DisclosureSEC source: 0001562180-20-005870 · primarydocument.xml · nonDerivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,484 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.89 to $32.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 19:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 14,090 | $31.29 | $440,876.10 |
DisclosureSEC source: 0001562180-20-005870 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,894 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.86 to $31.85, inclusive. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 19:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 27,500 | $10.80 | $297,000.00 |
DisclosureSEC source: 0001562180-20-005870 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,166 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · derivative · entry 8 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,166 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on Oct. 28, 2019. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,334 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · derivative · entry 7 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,889 Underlying: Common Stock · 1,334 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 472,223 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 17,870 | $35.70 | $637,959.00 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · nonDerivative · entry 6 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,484 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.43 to $35.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,334 | $35.19 | $46,943.46 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · nonDerivative · entry 5 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,354 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.42 to $35.41, inclusive. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 8,296 | $35.19 | $291,936.24 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · nonDerivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,688 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $34.42 to $35.41, inclusive. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 8,296 | $10.30 | $85,448.80 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · nonDerivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 17,870 | $10.30 | $184,061.00 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 19:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,334 | $10.80 | $14,407.20 |
DisclosureSEC source: 0001562180-20-005339 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 17:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-005000 · primarydocument.xml · derivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,166 Underlying: Common Stock · 27,500 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 17:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,800 | $29.79 | $83,412.00 |
DisclosureSEC source: 0001562180-20-005000 · primarydocument.xml · nonDerivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,484 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1 F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $29.55 to $30.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 17:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 24,700 | $28.82 | $711,854.00 |
DisclosureSEC source: 0001562180-20-005000 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,284 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1 F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.53 to $29.43, inclusive. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 17:50 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 27,500 | $10.30 | $283,250.00 |
DisclosureSEC source: 0001562180-20-005000 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 17:18 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,259 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001562180-20-004676 · primarydocument.xml · derivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,741 Underlying: Common Stock · 9,259 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option satisfied the time-based vesting condition on September 25, 2019 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the Reporting Person's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition was satisfied upon the Company's initial public offering. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 17:18 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,313 | $0.00 Strike: $15.84 | $0.00 |
DisclosureSEC source: 0001562180-20-004676 · primarydocument.xml · derivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,687 Underlying: Common Stock · 6,313 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option satisfied the time-based vesting condition on February 5, 2020 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the Reporting Person's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition was satisfied upon the Company's initial public offering. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 17:18 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 9,259 | $10.80 | $99,997.20 |
DisclosureSEC source: 0001562180-20-004676 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 17:18 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 6,313 | $15.84 | $99,997.92 |
DisclosureSEC source: 0001562180-20-004676 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 16:47 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-004169 · primarydocument.xml · derivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,666 Underlying: Common Stock · 27,500 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 16:47 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 27,500 | $26.97 | $741,675.00 |
DisclosureSEC source: 0001562180-20-004169 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,912 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.63 to $27.49, inclusive. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 16:47 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 27,500 | $10.30 | $283,250.00 |
DisclosureSEC source: 0001562180-20-004169 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-003394 · primarydocument.xml · derivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,166 Underlying: Common Stock · 27,500 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 27,500 | $25.37 | $697,675.00 |
DisclosureSEC source: 0001562180-20-003394 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,912 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 27,500 | $10.30 | $283,250.00 |
DisclosureSEC source: 0001562180-20-003394 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 20:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 48,850 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001562180-20-003209 · primarydocument.xml · derivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,850 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the 50,000 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Nov. 1, 2015. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 20:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,834 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-003209 · primarydocument.xml · derivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,834 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the 38,384 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Mar. 28, 2019. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 20:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 48,850 | $2.46 | $120,171.00 |
DisclosureSEC source: 0001562180-20-003209 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 20:09 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 38,834 | $10.30 | $399,990.20 |
DisclosureSEC source: 0001562180-20-003209 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 17:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-002899 · primarydocument.xml · derivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,666 Underlying: Common Stock · 27,500 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 17:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 7,878 | $26.03 | $205,064.34 |
DisclosureSEC source: 0001562180-20-002899 · primarydocument.xml · nonDerivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,228 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $26.00 to $26.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 17:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 19,622 | $25.56 | $501,538.32 |
DisclosureSEC source: 0001562180-20-002899 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,106 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.00 to $25.99, inclusive. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 17:52 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 27,500 | $10.30 | $283,250.00 |
DisclosureSEC source: 0001562180-20-002899 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $10.30 | $0.00 |
DisclosureSEC source: 0001562180-20-002257 · primarydocument.xml · derivative · entry 4 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,166 Underlying: Common Stock · 27,500 shares Expires 2025-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 3,900 | $29.33 | $114,387.00 |
DisclosureSEC source: 0001562180-20-002257 · primarydocument.xml · nonDerivative · entry 3 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,228 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F3 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.97 to $29.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 23,600 | $28.32 | $668,352.00 |
DisclosureSEC source: 0001562180-20-002257 · primarydocument.xml · nonDerivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,128 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1. F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $27.96 to $28.88, inclusive. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 27,500 | $10.30 | $283,250.00 |
DisclosureSEC source: 0001562180-20-002257 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,150 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001562180-20-000062 · primarydocument.xml · derivative · entry 2 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,850 Underlying: Common Stock · 1,150 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the 50,000 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Nov. 1, 2015. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:01 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Exercise / conversionCommon Stock | 1,150 | $2.46 | $2,829.00 |
DisclosureSEC source: 0001562180-20-000062 · primarydocument.xml · nonDerivative · entry 1 Sanders Dale · CIK 0001780970 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.